Clinical trials: Thin Endometrial Lining
Thin Endometrial Lining, Female Infertility
Evaluating Mechanically Engineered Stem Cell Exosomes for Treating Endometrial Injury: A Clinical Study
The goal of this clinical trial is to evaluate if engineered mechanically umbilical cord-derived stem cell exosomes, or conventional umbilical cord -derived stem cell exosomes, can improve endometrial thickness in women with thin…
- Conditions
- Thin Endometrial Lining, Female Infertility, Intrauterine Adhesions
- Trial name
- NCT06896747
- Testing
- Mechanically Engineered Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes, Umbilical cord mesenchymal stem cell-derived exosomes, platelet-rich plasma
- Where
- 2 sites in China
- Volunteers
- 90 people
- Sponsor
- Tang-Du Hospital
Asherman's Syndrome, Thin Endometrial Lining
Senescent Endometrial Cells in Patients with Thin Endometrial Lining
The goal of this observational study is to determine if thin endometrial lining that is unresponsive to estrogen might be associated with the presence of senescent cells in patients following long-term use of oral contraceptives.
- Conditions
- Asherman's Syndrome, Thin Endometrial Lining, Cell Senescence
- Trial name
- NCT06450301
- Testing
- Endometrial Biopsy
- Where
- Canada
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Trio Fertility
Infertility, Asherman's Syndrome
Platelet-rich Plasma (PRP) for Endometrial Regeneration and Repair
Patients with intrauterine adhesions (Asherman's Syndrome) and persistent thin endometrial lining in in vitro fertilization (IVF) treatment programs, particularly those resistant to standard therapies, present a significant…
- Trial name
- PRP-E (NCT02825849)
- Testing
- Intrauterine infusion of platelet rich plasma
- Where
- United States
- Volunteers
- 27 people, healthy volunteers welcome
- Sponsor
- University of California, San Francisco
Infertility of Uterine Origin
Endometrial Rejuvenation Study
To evaluate the response of the endometrial lining after subcutaneous administration of the medication AMD3100. This medication mobilizes stem cells and will be used in a population of infertile women with a thin endometrium who…
- Trial name
- NCT04045821
- Testing
- AMD3100, Normal saline, dilation and curettage
- Where
- 3 sites in United States
- Volunteers
- 3 people
- Sponsor
- Reproductive Medicine Associates of New Jersey